Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2017-05-23 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20170523 - Notifications de transparence BlackRock Inc.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled 'Déclarations de transparence' (Transparency Declarations) and explicitly mentions receiving four transparency declarations from BlackRock, Inc. regarding changes in its shareholding in UCB SA, crossing the 3% voting rights threshold downwards and upwards on multiple dates in May 2017. This content directly relates to notifications about changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). The document details the number of shares held, the percentage, and the dates the thresholds were crossed, which is the core function of a major shareholding disclosure.
2017-05-23 French
20170523 - Transparantieverklaringen BlackRock Inc.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaringen BlackRock, Inc." (Transparency Declarations BlackRock, Inc.) and explicitly mentions being 'gereglementeerde informatie' (regulated information) in Brussels. It details multiple notifications received by UCB NV from BlackRock, Inc. regarding changes in their shareholding percentage, specifically crossing the 3% threshold of voting rights, as required by the Belgian law of May 2, 2007 (Article 14). This type of filing, which reports changes in significant share ownership (crossing thresholds), directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it contains detailed tables, the core purpose is the notification of a change in major shareholding.
2017-05-23 Dutch
20170522 - Transparency notification Capital GC.pdf
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'transparency notification' received pursuant to Article 14 of the law regarding the 'disclosure of large shareholdings'. It details that The Capital Group Companies, Inc. has crossed the 10% ownership threshold in UCB SA/NV on a specific date (May 16, 2017). This content directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing regulatory thresholds. The appropriate code is MRQ.
2017-05-23 English
20170522 - Notification de transparence Capital GC.pdf
Director's Dealing Classification · 98% confidence The document is titled "Déclaration de transparence" (Transparency Declaration) and explicitly states it is an "information réglementée" (regulated information) received from The Capital Group Companies Inc. regarding an acquisition of voting shares in UCB SA. It details the crossing of a significant ownership threshold (10%) on May 16, 2017, and provides a breakdown of voting rights and the chain of controlled entities. This content directly corresponds to the definition of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels that cross regulatory thresholds. The appropriate code is MRQ.
2017-05-23 French
20170522 - Transparantieverklaring Capital GC.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states it is a notification received regarding the acquisition of UCB shares, causing the shareholder (The Capital Group Companies Inc.) to cross the 10% threshold of voting rights on May 16, 2017. This content directly relates to changes in significant share ownership levels, detailing the number of shares held and the percentage of total voting rights. This matches the definition for Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a simple announcement of a report's publication.
2017-05-23 Dutch
UCB ARCH May 22 2017 ENG
Regulatory Filings Classification · 95% confidence The document is a press release dated May 22, 2017, announcing top-line Phase 3 data for the drug EVENITY™ (romosozumab) from a study comparing it against alendronate. It details efficacy results (fracture reduction) and safety signals (cardiovascular events). The text explicitly mentions engagement with global regulators (FDA, Health Canada, PMDA) regarding regulatory submissions based on prior study results (FRAME). This type of announcement, detailing clinical trial results and their immediate impact on regulatory timelines (e.g., US approval expected later than 2017), is characteristic of an Earnings Release (ER) or a specific regulatory/clinical update. Since it focuses purely on the announcement of key financial/clinical results rather than being a full financial report (10-K/IR) or a transcript (CT), the most appropriate classification is Earnings Release (ER), as these often accompany or precede quarterly results announcements and contain critical operational/clinical milestones that affect outlook.
2017-05-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.